Sep 12, 2018

Bio+Tech18 conference set for Sept. 20 in Baltimore

The Maryland Tech Council is holding a biotechnology conference next week in Baltimore.

Jul 19, 2018

Gaithersburg biotech company raises $36 million

Gaithersburg biotech startup Neuraly has raised $36 million for its potential Alzheimer’s disease and Parkinson’s disease treatment, the company announced.

Feb 24, 2015

Vaccinogen relocates to Baltimore from Frederick

Vaccinogen Inc. has moved its corporate headquarters to Baltimore to take advantage of the city’s research institutions and biotechnology activity.

Jan 7, 2015

NIH partners with Vtesse Inc. to treat rare disease

The National Institutes of Health in Bethesda has partnered with Vtesse Inc., a Gaithersburg-based biotechnology company, to develop treatments for an often-fatal group of disorders known as lysosomal storage diseases.

Aug 20, 2014

Biotech awards focus on health care innovation

A state program that supports commercialization of biotechnology research is shifting its focus, and will now favor projects that can help improve health care quality while reducing costs.

Apr 30, 2014

Sanaria turns to crowdfunding website

Sanaria Inc., of Rockville, a biotechnology company that is developing an anti-malaria vaccine, said it aims to raise at least $250,000 in 30 days on, a crowdfunding website.

Apr 21, 2014

Emergent drug gets coveted FDA status

Emergent BioSolutions Inc., of Rockville, which develops and manufactures products that harness the immune system to treat and prevent disease, announced its BioThrax treatment for anthrax disease has been granted orphan drug status by the Food and Drug Administration for people with suspected or confirmed exposure to anthrax.

Dec 20, 2013

Germantown-based Intrexon agrees to acquire Medistem

Intrexon Corp., of Germantown, a developer of synthetic biological products targeting health, food, energy and environmental industries, said it has signed a definitive agreement to acquire San Diego-based Medistem Inc., a stem-cell company, in a cash-and-stock deal valued at approximately $26 million. Medistem is a developer of endometrial regenerative cells (ERCs), which are universal donor [&he[...]

Sep 30, 2013

Baltimore biotech Gliknik, Pfizer sign accord

Gliknik Inc., of Baltimore, a biotech that develops novel molecular treatments for autoimmune/inflammatory diseases and cancer, said it has entered into an exclusive worldwide licensing agreement with drug-making giant Pfizer Inc. for its pharmaceutical candidate, GL-2045, a potential treatment for a variety of autoimmune diseases.

Sep 18, 2013

Health IT startups eligible for funds, resources

You get money, a place to work, a mentor and access to resources. The rest is up to you.

Aug 6, 2013

UM Ventures announces license deals

University of Maryland Ventures, a joint research commercialization effort of the University of Maryland, Baltimore, and the University of Maryland, College Park, announced license and/or option agreements with five life sciences companies across the Baltimore-Washington region. The companies are Rexahn Pharmaceuticals Inc., of Rockville; IGI Technologies Inc., of Elkridge; Plasmonix Inc., of Arbu[...]

Aug 6, 2013

Ameritox acquires Ga.-based Prium

Ameritox L.P., of Baltimore, a pain medication monitoring provider offering specialized laboratory testing and reporting services for physicians, announced it has acquired Prium, of Duluth, Ga., a provider of medical cost management services for the workers' compensation market.

Networking Calendar

Submit an entry for the business calendar